Global Tuberculosis Clinical Trial Pipeline Report 2019 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global
Tuberculosis Clinical Trial Pipeline Highlights – 2019” report
has been added to ResearchAndMarkets.com’s offering.

Tuberculosis Pipeline Highlights – 2019, provides most
up-to-date information on key pipeline products in the global
Tuberculosis market. It covers emerging therapies for Tuberculosis in
active clinical development stages including early and late stage
clinical trials. The pipeline data presented in this report helps
executives in tracking competition, identifying partners, evaluating
opportunities, formulating business development strategies, and
executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Tuberculosis pipeline products by clinical trial
stages including both early and late stage development – phase 3
clinical trials, phase 2 clinical trials, phase 1 clinical trials,
preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Tuberculosis pipeline products by their dominant
mechanism of action/drug class. This helps executives categorize
products based on their drug class and also assess the strengths and
weaknesses of compounds.

Company:

The report provides Tuberculosis pipeline products by the company.

Short-term Launch Highlights:

Find out which Tuberculosis pipeline products will be launched in the US
and Ex-US to 2024.

Summary:

• Tuberculosis phase 3 clinical trial pipeline products
• Tuberculosis phase 2 clinical trial pipeline products
• Tuberculosis phase 1 clinical trial pipeline products
• Tuberculosis preclinical research pipeline products
• Tuberculosis discovery stage pipeline products
• Tuberculosis pipeline products short-term launch highlights

Key Topics Covered:

1. Tuberculosis Pipeline by Stages

2. Tuberculosis Phase 3 Clinical Trial Insights

3. Tuberculosis Phase 2 Clinical Trial Insights

4. Tuberculosis Phase 1 Clinical Trial Insights

5. Tuberculosis Preclinical Research Insights

6. Tuberculosis Discovery Stage Insights

7. Appendix

8. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/r/48k391

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Respiratory
Drugs, Infectious
Diseases Drugs, Clinical
Trials